Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
[Information processing speed and influential factors in multiple sclerosis].
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab.
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials.
Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis.
Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study.
DNA strand breakage by peroxidase-activated mitoxantrone.
Multiple sclerosis and risk of young-adult-onset Hodgkin lymphoma.
Two cases of relapses in primary progressive multiple sclerosis after fingolimod withdrawal.
The budget impact of introducing delayed-release dimethyl fumarate for treatment of relapse-remitting multiple sclerosis in Canada.
Glial cells as drug targets: What does it take?
IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis.
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Subcutaneous recombinant interferon-β-1a (Rebif®): a review of its use in the treatment of relapsing multiple sclerosis.
Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA
Glatiramer Acetate Guards Against Rapid Memory Decline During Relapsing-Remitting Experimental Autoimmune Encephalomyelitis.
Prevalence of people who could benefit from augmentative and alternative communication (AAC) in the UK: determining the need.
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.
Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results.
Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder.
Headache in relapse and remission phases of multiple sclerosis: A case-control study.
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity.
Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomas.
Clobetasol promotes remyelination in a mouse model of neuromyelitis optica.

Pages